Analgesic Agents and Pain Management

Pain is common, often under-recognised, and a major source of distress in critically ill patients, including those who cannot self-report. Analgesic agents — chiefly opioids, supplemented by multimodal non-opioid drugs and regional techniques — together with systematic pain assessment form the analgesia-first foundation of modern intensive care comfort management.

Definition

Analgesic agents are drugs that relieve pain; in critical care they are used within a structured approach of regular pain assessment and analgesia-based (analgesia-first) comfort management for mechanically ventilated and other critically ill patients.

Scope

This topic covers the assessment of pain in critically ill patients (including validated behavioural tools for those who cannot communicate), the principal analgesic agents, the multimodal and analgesia-first strategies, and the rationale for treating pain before adding sedation. It is a reference overview, not a guide to selecting or dosing analgesics.

Key concepts

• Opioids (e.g. fentanyl, morphine, remifentanil)
• Multimodal / opioid-sparing analgesia
• Analgesia-first (analgosedation) strategy
• Pain assessment in patients unable to self-report
• Behavioral Pain Scale (BPS)
• Critical-Care Pain Observation Tool (CPOT)
• Procedural pain in the ICU

Mechanisms

Opioids, the mainstay of ICU analgesia, act on mu-opioid receptors in the central nervous system to reduce pain transmission and perception; their effects and offset depend on the specific agent's pharmacokinetics. Multimodal analgesia adds non-opioid agents acting through different pathways to lower opioid requirements and side effects. Because many critically ill patients cannot self-report pain, behavioural tools such as the Behavioral Pain Scale and the Critical-Care Pain Observation Tool infer pain from observable indicators (facial expression, movement, ventilator interaction), enabling assessment-driven analgesia.

Clinical relevance

Untreated pain causes distress, contributes to agitation and delirium, and can worsen physiological stress, so reliable pain assessment and analgesia are core competencies in critical care. The PADIS guidelines describe assessment-driven, analgesia-first management; this entry summarises that framework for orientation and is not a basis for individual prescribing.

Epidemiology

Pain is reported by a large fraction of ICU patients, both at rest and during routine procedures, and it is frequently underestimated when not formally assessed, which is why guidelines emphasise validated tools such as BPS and CPOT for patients who cannot communicate.

Evidence & guidelines

The 2018 PADIS guidelines (Devlin et al.) recommend routinely assessing pain and using an analgesia-first approach, endorsing the Behavioral Pain Scale (Payen et al., 2001) and the Critical-Care Pain Observation Tool (Gélinas et al., 2006) as validated instruments for patients unable to self-report.

History

Pain in critically ill, sedated patients was long under-assessed because such patients cannot reliably self-report. The development and validation of behavioural pain tools (BPS in 2001, CPOT in 2006) and the articulation of analgesia-first sedation in the 2013 and 2018 SCCM guidelines established systematic ICU pain management.

Key figures

• John Devlin
• Jean-François Payen
• Céline Gélinas
• Kathleen Puntillo

Seminal works

• devlin-2018
• payen-2001
• gelinas-2006

Frequently asked questions

How is pain assessed in a patient who cannot speak?

Validated behavioural tools such as the Behavioral Pain Scale and the Critical-Care Pain Observation Tool infer pain from observable signs like facial expression, body movement and ventilator synchrony.

What does 'analgesia-first' mean?

It is the strategy of treating pain before adding sedatives, since adequate analgesia can reduce agitation and the amount of sedation needed.